NCT06257628 is a clinical trial of Index Event in Cardiac Events, sponsored by Beckman Coulter, Inc..

Who is sponsoring NCT06257628?

NCT06257628 is sponsored by Beckman Coulter, Inc..

What drugs are being tested in NCT06257628?

Interventions in NCT06257628: Index Event.

What condition does NCT06257628 study?

NCT06257628 studies Cardiac Events.

Is NCT06257628 still recruiting?

NCT06257628 is currently withdrawn. Last updated 12 November 2025.

Last reviewed 2025-11-12 · How we verify

NCT06257628

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

MACE CDS Software Master Enrollment Protocol

Withdrawn Last updated 12 November 2025

What this trial tests

trial testing Index Event in Cardiac Events. Withdrawn.

Timeline

14 September 2023

Primary endpoint
31 May 2025

31 May 2025

Quick facts

Lead sponsor	Beckman Coulter, Inc.
Status	Withdrawn
Study type	OBSERVATIONAL
Start date	14 September 2023
Primary completion	31 May 2025
Estimated completion	31 May 2025
Sites	3 locations across United States

Drugs / interventions tested

Index Event

Conditions studied

Cardiac Events — all drugs for Cardiac Events →

Sponsor

Beckman Coulter, Inc.

Who can join

23 and older, any sex, with Cardiac Events. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This protocol will collect real world EHR data to support the product development life cycle activities associated with developing the Major Adverse Cardiac Events (MACE) Clinical Decision Support (CDS) software. The data will also be utilized in subsequent clinical validation to support an FDA application and/or applications to other regulatory agencies as needed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiac Events

Currently open trials in the same condition.

NCT06486636 — Pericardiotomy in Cardiac Surgery · NA · recruiting
NCT06744088 — Clinical Outcomes Of Modified Del Nido Cardioplegia In Adult And Pediatric Cardiac Surgery · active not recruiting

Other Beckman Coulter, Inc. trials

Trials by the same sponsor.

NCT07217431 — Access BNP Clinical Performance Evaluation: Testing and Clinical Concordance Study · completed
NCT06624293 — Access BNP Clinical Enrollment Study · completed
NCT06379061 — Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts · completed
NCT06289868 — Access Anti-HAV and Access Anti-HAV IgM Assays EU Clinical Trial Protocol (HAV-EU-11-23) · completed
NCT05819762 — Evaluation of ClearLLab LS Screening Panel · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06257628 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beckman Coulter, Inc.
Last refreshed: 12 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06257628.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing